Description
AICAR is a cell-permeable adenosine analog and one of the most widely used pharmacological tools for studying AMP-activated protein kinase (AMPK) signaling in cellular and metabolic research. Once taken up by cells via adenosine transporters, it is phosphorylated by adenosine kinase to form ZMP — an AMP mimetic that binds the γ-subunit of AMPK and activates it without altering the cellular ADP:ATP ratio or directly inhibiting mitochondrial function. This mechanism makes AICAR a useful tool for isolating AMPK-dependent signaling from the confounding metabolic effects that indirect AMPK activators typically introduce.
Key Characteristics
- Activates AMPK through ZMP accumulation — ZMP mimics AMP at the γ-subunit allosteric site without changing oxygen uptake or the ADP:ATP ratio, which distinguishes this activation mechanism from indirect AMPK activators such as metformin
- ZMP is a natural intermediate in the purine nucleotide synthesis pathway, metabolized by AICAR transformylase — this dual role as a research tool and endogenous metabolic intermediate adds interpretive complexity that researchers account for in study design
- AICAR effects extend beyond AMPK: a growing body of literature documents AMPK-independent signaling through pathways including mTOR, p53, and purine synthesis — making it a compound that probes multiple nodes simultaneously rather than a single-pathway tool
- Shares downstream pathway convergence with MOTS-c, a mitochondrial-derived peptide that also activates AMPK through a distinct upstream mechanism, making both compounds relevant in comparative AMPK biology study designs
- Extensively characterized in skeletal muscle, liver, and cancer cell models — one of the most cited pharmacological AMPK research tools in the academic literature
Handling and Storage
Store as lyophilized powder away from heat, moisture, and direct light. Refrigeration is recommended for long-term storage. Reconstitute immediately before use and avoid repeated freeze-thaw cycles to maintain compound integrity and experimental consistency.
FAQs
What is AICAR used for in research?
AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is used as a pharmacological AMPK activator in cellular and metabolic research. Once inside the cell, it is converted to ZMP, an AMP mimetic that activates AMPK at the γ-subunit without altering the ADP:ATP ratio. Researchers use it to study AMPK-dependent signaling in metabolic, muscle, liver, and cancer biology models.
How does AICAR differ from other AMPK activators in research models?
Unlike indirect AMPK activators such as metformin — which activates AMPK by inhibiting mitochondrial Complex I and raising intracellular AMP — AICAR generates ZMP, which mimics AMP directly at the AMPK γ-subunit without disrupting mitochondrial function. This distinction is relevant for study designs that need to isolate AMPK activation from broader energetic stress effects. Researchers should also account for AICAR’s documented AMPK-independent effects, which include interactions with mTOR and purine synthesis pathways.
How should AICAR be stored?
Store as lyophilized powder under refrigeration, away from heat, light, and moisture. Reconstitute immediately before experimental use and avoid repeated freeze-thaw cycles, which can reduce compound stability and introduce variability into AMPK activation assays.
